Communicable Diseases Surveillance Bulletin 2005 Nov;(11):3-4

Communicable Diseases Surveillance Bulletin 2005 Nov;(11):3-4

Communicable Diseases NICD Surveillance Bulletin March 2006 A quarterly publication of the National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS) CONTENTS NICD provisional listing of diseases under laboratory surveillance ............. 2 South African Laboratory Surveillance for enteric disease, 2005................. 3 Respiratory and meningeal pathogen surveillance, South Africa, 2005.............................................................................................. 4 Cryptococcal surveillance, South Africa, 2005................................................ 8 Anthrax in South Africa, 2005............................................................................ 9 National clinical surveilance for sexually transmitted infections.................. 10 Microbiological surveillance of sexually transmitted infections................... 10 Suspected measles case based surveillance, South Africa, 2005................. 11 Acute flaccid paralysis (AFP) surveillance, Southern Africa, 2005............... 12 Respiratory virus surveillance, 2005................................................................. 14 African trypanosomiasis in 2005....................................................................... 15 Viral haemorrhagic fevers (VHF) and rabies.................................................... 16 This bulletin is available on the NICD website : http://www.nicd.ac.za Requests for e-mail subscription are invited - please send request to Mrs Liz Millington : [email protected] Material from this publication may be freely reproduced provided due acknowledgement is given to the author, the Bulletin and the NICD 1 Provisional listing: number of laboratory-confirmed cases in South Africa of diseases under surveillance reported to the NICD, corresponding periods 1 January-31 December 2004/2005 Disease/ Cumulative to Case Definition Subgroup EC FS GA KZ LP MP NC NW WC South Africa Organism 31 Dec, year Acute Flaccid Cases < 15 years of age from whom specimens have been 2004 24 17 28 36 56 14 5 25 25 230 <=15 years Paralysis received as part of the Polio Eradication Programme 2005 25 16 27 36 58 14 5 25 26 232 Measles IgM positive cases from suspected measles cases, 2004 7 0 560 90 5 11 4 10 33 720 Measles All ages all ages 2005 478 1 44 74 2 5 0 1 16 621 Rubella IgM positive cases from suspected measles cases , 2004 104 2 245 31 40 285 4 122 20 853 Rubella All ages all ages 2005 162 28 277 166 63 125 77 79 35 1012 Laboratory-confirmed cases of CCHF (unless otherwise 2004 0 1 0 0 0 0 1 2 0 4 VHF All ages stated), all ages 2005 0 0 0 0 0 0 0 0 1 1 VIRAL DISEASES DISEASES VIRAL Rabies Laboratory-confirmed human cases, all ages All ages 2004 0 0 0 6 0 1 0 0 0 7 2005 4 1 0 2 0 0 0 0 0 7 2004 9 13 132 29 2 6 1 3 41 236 Invasive disease, all ages All serotypes 2005 10 21 132 29 1 10 2 1 42 248 2004 1 2 21 2 1 1 0 0 4 32 Serotype b 2005 4 3 18 4 0 0 0 1 6 36 Haemophilus 2004 1 0 7 2 0 0 0 0 3 13 Serotypes a,c,d,e,f influenzae 2005 1 1 9 2 0 1 0 0 5 19 Invasive disease, < 5 years Non-typeable 2004 0 6 30 7 0 0 0 0 11 54 (unencapsulated) 2005 2 4 39 4 0 2 0 0 5 56 No isolate available 2004 3 2 12 6 0 1 1 1 7 33 for serotyping 2005 0 2 12 3 0 2 0 0 10 29 Neisseria 2004 29 22 184 23 9 11 6 18 58 360 Invasive disease, all ages meningitidis 2005 10 25 355 25 12 21 8 15 68 539 SES 2004 161 216 2024 496 68 180 21 114 504 3784 Total cases 2005 215 215 2225 467 73 229 32 114 478 4048 Penicillin non- 2004 63 77 643 175 18 46 6 33 220 1281 Invasive disease, all ages Streptococcus susceptible isolates 2005 73 74 600 175 19 64 5 23 196 1229 pneumoniae No isolate available 2004 33 43 546 145 12 40 1 29 119 968 for susceptibility 2005 52 56 652 139 16 56 8 23 130 1132 2004 9 21 189 25 9 15 0 6 37 311 Invasive disease, < 5 years 2005 22 10 243 37 12 21 3 10 31 389 2004 19 15 597 69 3 15 0 6 65 790 Invasive disease, all ages Salmonella spp. 2005 38 26 523 104 9 36 0 4 68 808 (not typhi) 2004 127 30 262 166 39 12 0 28 160 824 Confirmed cases, isolate from a non-sterile site, all ages 2005 143 31 206 178 29 70 7 43 173 880 Salmonella 2004 13 0 20 8 7 9 0 0 10 67 BACTERIAL AND FUNGAL DISEA Confirmed cases, isolate from any specimen, all ages typhi 2005 31 0 32 12 8 91 0 0 10 184 Shigella 2004 0 0 0 1 0 0 0 0 0 1 Confirmed cases, isolate from any specimen dysenteriae 1 2005 0 0 0 0 0 0 0 0 5 5 Shigella spp. 2004 114 48 226 149 33 12 0 15 361 958 Confirmed cases, isolate from any specimen, all ages All serotypes (Non Sd1) 2005 145 36 264 178 19 55 8 15 317 1037 Vibrio cholerae 2004 23 0 3 0 0 213 0 28 0 267 Confirmed cases, isolate from any specimen, all ages All serotypes O1 2005 0 0 0 0 0 0 0 0 0 0 2004 U U U U U U U U U U Cryptococcus C. gattii Invasive disease, all ages 2005 2 3 27 15 16 14 0 8 7 92 spp. C. neoformans 2004 U U U U U U U U U U 2005 448 245 1611 941 133 358 40 237 343 4356 Abbreviations: VHF - Viral Haemorrhagic Fever; CCHF - Crimean-Congo Haemorrhagic Fever Provinces of South Africa: EC – Eastern Cape, FS – Free State, GA – Gauteng, KZ – KwaZulu-Natal, LP – Limpopo, MP – Mpumalanga, NC – Northern Cape, NW – North West, WC – Western Cape U = unavailable, 0 = no cases reported SOUTH AFRICAN LABORATORY SURVEILLANCE FOR ENTERIC DISEASE, 2005 Karen Keddy, EDRU, NICD During the year, enteric surveillance specimens were Invasive salmonellosis was predominantly seen in the received from all the provinces, with a greater than 10 very young and the 20-40 year age group, unlike the % increase in the number of specimens noted for the disease in developed countries, where it is associated whole of South Africa. This was primarily due to with extremes of age. Noteworthy features included increased numbers of isolates from the laboratories the number of CNS and pulmonary infections. Non- in KwaZulu-Natal and the Northern Cape, and may invasive specimens primarily included stool not reflect a real increase in isolates sent to the Enteric specimens, where Salmonella Typhimurium and Diseases Reference Unit (EDRU), but rather an Salmonella Isangi again predominated, and were increase in awareness regarding surveillance. multi-drug resistant. Of the Salmonella isolates received, there was a Slightly more than 1 000 Shigella isolates were marked predominance of Salmonella Typhimurium, received. Most Shigella isolates were from stool the majority of which were resistant to four or more specimens. Shigella flexneri 2a remained the antimicrobials. Approximately 50% of isolates were commonest isolate, as would be expected in a from invasive cultures. Multi-drug resistant Salmonella developing country. Other serotypes of S. flexneri Isangi represented about 1/3 of all the isolates received, were also common, with differing frequencies in probably reflecting ongoing nosocomial transmission, different provinces. S. sonnei I and II were seen less and Salmonella Typhi became the third commonest frequently and appeared to have a more urban isolate as a result of the outbreak in Delmas, distribution. As these last two are the commonest Mpumalanga. Salmonella Enteritidis, which was also isolates in the developed world, this probably reflects common, has remained relatively susceptible to most the differences in service delivery and the availability antimicrobials; with only four of the 95 strains received of potable water between the more rural and the urban producing ESBL (extended spectrum beat lactamase). areas of South Africa. S. dysenteriae type 1 now appears to be a rare isolate, with only five isolates Antimicrobial resistance in Salmonella Typhi appears being received from the Western Cape, and none from to be increasing. Approximately 15% of isolates were KwaZulu-Natal. resistant to antibiotics previously recommended as first line therapy, including ampicillin and Shigella isolates were primarily from stool specimens, cotrimoxazole, although only 4 of 185 isolates were reflecting that this organism usually causes more chloramphenicol resistant. A worrying trend is 11 of severe diarrhoea or dysentery and may be associated 185 strains being resistant to nalidixic acid. Note with outbreaks because of the small infectious dose. that these results are arguably skewed, as the As a result, practices regarding submission of stools seventy-odd typhoid strains from Delmas, which could for culture may be skewed towards identifying this be epidemiologically linked, were all fully sensitive. organism, resulting in a predominance of Shigella isolates from stool specimens received by EDRU. Salmonella isolates from enhanced surveillance were Most isolates (80%) were resistant to cotrimoxazole a representative reflection of the HIV situation at these and about 40% were resistant to ampicillin. Serotype sites. Invasive cases vastly outnumbered non-invasive had little impact on antimicrobial resistance, with the cases and quinolone resistance and ESBL production exception of Shigella dysenteriae type 1: four of the were high in the commoner serotypes. There were a five isolates received were resistant to ampicillin, number of refractory infections in patients, as trimethoprim, sulfamethoxazole and tetracycline. No evidenced by repeat specimens sent within the same nalidixic acid resistance was detected in these five period of hospitalisation. Also noteworthy were the isolates. Nalidixic acid resistance in Shigella isolates number of recurrent infections, particularly in immune is till rare (approximately 1% of isolates) and this suppressed patients.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    16 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us